Loading, please wait ...

This site requires JavaScript. It will only be visible if you have it enabled.

Skip

Featured

News Analytics

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA® (guselkumab) and Long-Term Safety Profile for STELARA® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week® 2022 | Johnson & Johnson

Content Lab U.S.

53 years ago

Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA ® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week ® 2022 Janssen Presents Study Results Showing Clinical Efficacy for TREMFYA ® (guselkumab) and Long-Term Safety Profile for STELARA ® (ustekinumab) for Patients Living with Inflammatory Bowel Disease at Digestive Disease Week ® 2022 Other data presented demonstrate ...

Concept Cloud

Google

#EndResultsProgram

#TheAmericanGastroenterologicalAssociation

#NativeHawaiian

#AmericanIndian

#MonoclonalAntibodySpecific

#TREMFYAPrescribingInformation

#RemoPanaccione

#PooledSafetyAnalysis

#Gastroenterology

#GastroenterologyDiseaseAreaLeader

#ProductCharacteristics

#STELARAPrescribingInformation

#ThePharmaceuticalCompaniesofJohnsonJohnson

#TheAmericanAssociationfortheStudyofLiverDiseases

#NationalCancerInstituteSurveillanceEpidemiology

#SubunitofInterleukin23

#TheSocietyforSurgeryoftheAlimentaryTract

#MedicationGuide

#TheUnitedStates

#EUClinicalTrialsRegister

#TheNationalInstitutesofHealthSurveillanceEpidemiology

#SafetyofUstekinumab

#PulmonaryHypertension

#TheSecuritiesandExchangeCommission

#JohnsonJohnsonsAnnualReportonForm

#ClinicalEfficacy

#TheAmericanSocietyforGastrointestinalEndoscopy

#InfectiousDiseasesVaccines

#Up4Comparisons

#JohnsonJohnson

#CrohnsColitisFoundation

#TheCanadianAgencyforDrugsTechnologies

#PrescribingInformation

#JapanPharmaceuticalsandMedicalDevicesAgency

#FoodandDrugAdministration

#JanssenPharmaceuticalCompanies

#SEERCancerStatisticsReview

#CumulativeSafetyofUstekinumab

#SimpleEndoscopicScore

#UlcerativeColitis

#PatientsTreated

#TheInflammatoryBowelDiseaseUnit

#TheUniversityofCalgary

#LeastSquaresMean

#AfricanAmerican

#LongTermSafetyProfile

#Week48Analyses

#CardiovascularMetabolismRetina

#LongtermEfficacy

#JanssenResearchDevelopment

#EuropeanMedicinesAgency

#Httpsseercancergovarchivecsr19752016resultsfiguresect01intro225pgspdfAccessed

#SafetyofGuselkumab

#SafetyofGuselkumabMaintenanceTherapy

#QuarterlyReports

#PatientswithModeratelytoSeverelyActiveCrohn

#PsoriaticArthritis

#PrescribingInformationandMedicationGuide

#SymptomsofUlcerativeColitis

#TheJanssenPharmaceuticalCompanies

#PatientsLivingwithInflammatoryBowelDisease

#PacificIslander

#ArthritisRheumatology

#IncidenceRatio

#EndResultsProgram

#TheAmericanGastroenterologicalAssociation

#NativeHawaiian

#AmericanIndian

#MonoclonalAntibodySpecific

#TREMFYAPrescribingInformation

#RemoPanaccione

#PooledSafetyAnalysis

#Gastroenterology

#GastroenterologyDiseaseAreaLeader

#ProductCharacteristics

#STELARAPrescribingInformation

#ThePharmaceuticalCompaniesofJohnsonJohnson

#TheAmericanAssociationfortheStudyofLiverDiseases

#NationalCancerInstituteSurveillanceEpidemiology

#SubunitofInterleukin23

#TheSocietyforSurgeryoftheAlimentaryTract

#MedicationGuide

#TheUnitedStates

#EUClinicalTrialsRegister

#TheNationalInstitutesofHealthSurveillanceEpidemiology

#SafetyofUstekinumab

#PulmonaryHypertension

#TheSecuritiesandExchangeCommission

#JohnsonJohnsonsAnnualReportonForm

#ClinicalEfficacy

#TheAmericanSocietyforGastrointestinalEndoscopy

#InfectiousDiseasesVaccines

#Up4Comparisons

#JohnsonJohnson

#CrohnsColitisFoundation

#TheCanadianAgencyforDrugsTechnologies

#PrescribingInformation

#JapanPharmaceuticalsandMedicalDevicesAgency

#FoodandDrugAdministration

#JanssenPharmaceuticalCompanies

#SEERCancerStatisticsReview

#CumulativeSafetyofUstekinumab

#SimpleEndoscopicScore

#UlcerativeColitis

#PatientsTreated

#TheInflammatoryBowelDiseaseUnit

#TheUniversityofCalgary

#LeastSquaresMean

#AfricanAmerican

#LongTermSafetyProfile

#Week48Analyses

#CardiovascularMetabolismRetina

#LongtermEfficacy

#JanssenResearchDevelopment

#EuropeanMedicinesAgency

#Httpsseercancergovarchivecsr19752016resultsfiguresect01intro225pgspdfAccessed

#SafetyofGuselkumab

#SafetyofGuselkumabMaintenanceTherapy

#QuarterlyReports

#PatientswithModeratelytoSeverelyActiveCrohn

#PsoriaticArthritis

#PrescribingInformationandMedicationGuide

#SymptomsofUlcerativeColitis

#TheJanssenPharmaceuticalCompanies

#PatientsLivingwithInflammatoryBowelDisease

#PacificIslander

#ArthritisRheumatology

#IncidenceRatio

#EndResultsProgram

#TheAmericanGastroenterologicalAssociation

#NativeHawaiian

#AmericanIndian

#MonoclonalAntibodySpecific

#TREMFYAPrescribingInformation

#RemoPanaccione

#PooledSafetyAnalysis

#Gastroenterology

#GastroenterologyDiseaseAreaLeader

#ProductCharacteristics

#STELARAPrescribingInformation

#ThePharmaceuticalCompaniesofJohnsonJohnson

#TheAmericanAssociationfortheStudyofLiverDiseases

#NationalCancerInstituteSurveillanceEpidemiology

#SubunitofInterleukin23

#TheSocietyforSurgeryoftheAlimentaryTract

#MedicationGuide

#TheUnitedStates

#EUClinicalTrialsRegister

#TheNationalInstitutesofHealthSurveillanceEpidemiology

#SafetyofUstekinumab

#PulmonaryHypertension

#TheSecuritiesandExchangeCommission

#JohnsonJohnsonsAnnualReportonForm

#ClinicalEfficacy

#TheAmericanSocietyforGastrointestinalEndoscopy

#InfectiousDiseasesVaccines

#Up4Comparisons

#JohnsonJohnson

#CrohnsColitisFoundation

#TheCanadianAgencyforDrugsTechnologies

#PrescribingInformation

#JapanPharmaceuticalsandMedicalDevicesAgency

#FoodandDrugAdministration

#JanssenPharmaceuticalCompanies

#SEERCancerStatisticsReview

#CumulativeSafetyofUstekinumab

#SimpleEndoscopicScore

#UlcerativeColitis

#PatientsTreated

#TheInflammatoryBowelDiseaseUnit

#TheUniversityofCalgary

#LeastSquaresMean

#AfricanAmerican

#LongTermSafetyProfile

#Week48Analyses

#CardiovascularMetabolismRetina

#LongtermEfficacy

#JanssenResearchDevelopment

#EuropeanMedicinesAgency

#Httpsseercancergovarchivecsr19752016resultsfiguresect01intro225pgspdfAccessed

#SafetyofGuselkumab

#SafetyofGuselkumabMaintenanceTherapy

#QuarterlyReports

#PatientswithModeratelytoSeverelyActiveCrohn

#PsoriaticArthritis

#PrescribingInformationandMedicationGuide

#SymptomsofUlcerativeColitis

#TheJanssenPharmaceuticalCompanies

#PatientsLivingwithInflammatoryBowelDisease

#PacificIslander

#ArthritisRheumatology

#IncidenceRatio

#EndResultsProgram

#TheAmericanGastroenterologicalAssociation

#NativeHawaiian

#AmericanIndian

#MonoclonalAntibodySpecific

#TREMFYAPrescribingInformation

#RemoPanaccione

#PooledSafetyAnalysis

#Gastroenterology

#GastroenterologyDiseaseAreaLeader

#ProductCharacteristics

#STELARAPrescribingInformation

#ThePharmaceuticalCompaniesofJohnsonJohnson

#TheAmericanAssociationfortheStudyofLiverDiseases

#NationalCancerInstituteSurveillanceEpidemiology

#SubunitofInterleukin23

#TheSocietyforSurgeryoftheAlimentaryTract

#MedicationGuide

#TheUnitedStates

#EUClinicalTrialsRegister

#TheNationalInstitutesofHealthSurveillanceEpidemiology

#SafetyofUstekinumab

#PulmonaryHypertension

#TheSecuritiesandExchangeCommission

#JohnsonJohnsonsAnnualReportonForm

#ClinicalEfficacy

#TheAmericanSocietyforGastrointestinalEndoscopy

#InfectiousDiseasesVaccines

#Up4Comparisons

#JohnsonJohnson

#CrohnsColitisFoundation

#TheCanadianAgencyforDrugsTechnologies

#PrescribingInformation

#JapanPharmaceuticalsandMedicalDevicesAgency

#FoodandDrugAdministration

#JanssenPharmaceuticalCompanies

#SEERCancerStatisticsReview

#CumulativeSafetyofUstekinumab

#SimpleEndoscopicScore

#UlcerativeColitis

#PatientsTreated

#TheInflammatoryBowelDiseaseUnit

#TheUniversityofCalgary

#LeastSquaresMean

#AfricanAmerican

#LongTermSafetyProfile

#Week48Analyses

#CardiovascularMetabolismRetina

#LongtermEfficacy

#JanssenResearchDevelopment

#EuropeanMedicinesAgency

#Httpsseercancergovarchivecsr19752016resultsfiguresect01intro225pgspdfAccessed

#SafetyofGuselkumab

#SafetyofGuselkumabMaintenanceTherapy

#QuarterlyReports

#PatientswithModeratelytoSeverelyActiveCrohn

#PsoriaticArthritis

#PrescribingInformationandMedicationGuide

#SymptomsofUlcerativeColitis

#TheJanssenPharmaceuticalCompanies

#PatientsLivingwithInflammatoryBowelDisease

#PacificIslander

#ArthritisRheumatology

#IncidenceRatio

#EndResultsProgram

#TheAmericanGastroenterologicalAssociation

#NativeHawaiian

#AmericanIndian

#MonoclonalAntibodySpecific

#TREMFYAPrescribingInformation

#RemoPanaccione

#PooledSafetyAnalysis

#Gastroenterology

#GastroenterologyDiseaseAreaLeader

#ProductCharacteristics

#STELARAPrescribingInformation

#ThePharmaceuticalCompaniesofJohnsonJohnson

#TheAmericanAssociationfortheStudyofLiverDiseases

#NationalCancerInstituteSurveillanceEpidemiology

#SubunitofInterleukin23

#TheSocietyforSurgeryoftheAlimentaryTract

#MedicationGuide

#TheUnitedStates

#EUClinicalTrialsRegister

#TheNationalInstitutesofHealthSurveillanceEpidemiology

#SafetyofUstekinumab

#PulmonaryHypertension

#TheSecuritiesandExchangeCommission

#JohnsonJohnsonsAnnualReportonForm

#ClinicalEfficacy

#TheAmericanSocietyforGastrointestinalEndoscopy

#InfectiousDiseasesVaccines

#Up4Comparisons

#JohnsonJohnson

#CrohnsColitisFoundation

#TheCanadianAgencyforDrugsTechnologies

#PrescribingInformation

#JapanPharmaceuticalsandMedicalDevicesAgency

#FoodandDrugAdministration

#JanssenPharmaceuticalCompanies

#SEERCancerStatisticsReview

#CumulativeSafetyofUstekinumab

#SimpleEndoscopicScore

#UlcerativeColitis

#PatientsTreated

#TheInflammatoryBowelDiseaseUnit

#TheUniversityofCalgary

#LeastSquaresMean

#AfricanAmerican

#LongTermSafetyProfile

#Week48Analyses

#CardiovascularMetabolismRetina

#LongtermEfficacy

#JanssenResearchDevelopment

#EuropeanMedicinesAgency

#Httpsseercancergovarchivecsr19752016resultsfiguresect01intro225pgspdfAccessed

#SafetyofGuselkumab

#SafetyofGuselkumabMaintenanceTherapy

#QuarterlyReports

#PatientswithModeratelytoSeverelyActiveCrohn

#PsoriaticArthritis

#PrescribingInformationandMedicationGuide

#SymptomsofUlcerativeColitis

#TheJanssenPharmaceuticalCompanies

#PatientsLivingwithInflammatoryBowelDisease

#PacificIslander

#ArthritisRheumatology

#IncidenceRatio

Related Videos On YouTube

The Angle

Subject Matter

Healthcare 100.00%

Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions

Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.

Content Search

Search something

NLP Visualization

© 2021 TheNewsHOOK. Created with | Use your content | Chrome add-on | Privacy | Terms